Mercator Medical S.A.
MRC.WA · WSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | PLN 543 | PLN 469 | PLN 543 | PLN 1,727 |
| % Growth | 15.7% | -13.5% | -68.6% | – |
| Cost of Goods Sold | PLN 402 | PLN 445 | PLN 454 | PLN 1,044 |
| Gross Profit | PLN 141 | PLN 103 | PLN 88 | PLN 684 |
| % Margin | 26% | 21.9% | 16.3% | 39.6% |
| R&D Expenses | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| G&A Expenses | PLN 0 | PLN 0 | PLN 62 | PLN 62 |
| SG&A Expenses | PLN 133 | PLN 127 | PLN 62 | PLN 62 |
| Sales & Mktg Exp. | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Other Operating Expenses | -PLN 23 | PLN 63 | PLN 100 | PLN 159 |
| Operating Expenses | PLN 110 | PLN 190 | PLN 162 | PLN 220 |
| Operating Income | PLN 31 | -PLN 87 | -PLN 181 | PLN 463 |
| % Margin | 5.7% | -18.6% | -33.4% | 26.8% |
| Other Income/Exp. Net | PLN 11 | PLN 83 | -PLN 5 | PLN 14 |
| Pre-Tax Income | PLN 42 | -PLN 4 | -PLN 186 | PLN 477 |
| Tax Expense | -PLN 8 | PLN 19 | PLN 5 | PLN 32 |
| Net Income | PLN 51 | -PLN 20 | -PLN 190 | PLN 447 |
| % Margin | 9.4% | -4.2% | -35% | 25.9% |
| EPS | 5.44 | -2.05 | -19.41 | 44.15 |
| % Growth | 365.4% | 89.4% | -144% | – |
| EPS Diluted | 5.44 | -2.05 | -19.41 | 44.15 |
| Weighted Avg Shares Out | 9 | 10 | 10 | 10 |
| Weighted Avg Shares Out Dil | 9 | 10 | 10 | 10 |
| Supplemental Information | – | – | – | – |
| Interest Income | PLN 21 | PLN 23 | PLN 13 | PLN 3 |
| Interest Expense | PLN 0 | PLN 1 | PLN 1 | PLN 1 |
| Depreciation & Amortization | PLN 19 | PLN 22 | PLN 26 | PLN 19 |
| EBITDA | -PLN 5 | -PLN 51 | -PLN 160 | PLN 497 |
| % Margin | -0.9% | -11% | -29.4% | 28.8% |